Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
p decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 p » 19 _ (Expand Search)
Showing 61 - 80 results of 79,666 for search '(( 19 p decrease ) OR ( 5 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.02s Refine Results
  1. 61
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Data_Sheet_1_Risk of psychological distress by decrease in economic activity, gender, and age due to COVID-19: A multinational study.PDF

    Data_Sheet_1_Risk of psychological distress by decrease in economic activity, gender, and age due to COVID-19: A multinational study.PDF by Minji Kim (1722313)

    Published 2023
    “…</p>Discussion<p>Psychological distress due to COVID-19 revealed a significant association with decrease in economic activity, women, and younger age. …”
    Save to List
    Saved in:
  12. 72
    Decreased transcription of <i>prs</i> results in decreased growth.

    Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  13. 73
    Acute starvation decreases the Brp::rGFP heterogeneity level among γcompartments.

    Acute starvation decreases the Brp::rGFP heterogeneity level among γcompartments. by Hongyang Wu (8856740)

    Published 2025
    Save to List
    Saved in:
  14. 74
    TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin.

    TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin. by Martin Selinger (3195987)

    Published 2019
    Save to List
    Saved in:
  15. 75
    Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake.

    Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

    Published 2019
    Save to List
    Saved in:
  16. 76
    ND-75<sup>KD</sup> flies have reduced mobility, seizures and decreased lifespan.

    ND-75<sup>KD</sup> flies have reduced mobility, seizures and decreased lifespan. by Lucy Granat (5570813)

    Published 2023
    Save to List
    Saved in:
  17. 77
    TG6-44 treatment decreases IFN-β levels in A/X31-infected THP-1 cells.

    TG6-44 treatment decreases IFN-β levels in A/X31-infected THP-1 cells. by Juan A. De La Cruz (11154187)

    Published 2021
    Save to List
    Saved in:
  18. 78
    TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells.

    TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

    Published 2021
    Save to List
    Saved in:
  19. 79
    Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability.

    Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

    Published 2022
    “…<p>(A1) Modification of model. Increased basal phosphorylation of CREB <i>k</i><sub><i>basalp_creb</i></sub>, concurrent with decreased basal phosphorylation of CaMKIIα <i>k</i><sub><i>basalp_CaMKII</i></sub>, in the absence of the effects of MeCP2/HDAC2/Sin3a (red) ([<i>E</i><sub><i>comp</i></sub>] = 0; [<i>E</i><sub><i>MeCP2</i></sub>] = 0). …”
    Save to List
    Saved in:
  20. 80
    Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells.

    Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

    Published 2023
    Save to List
    Saved in:

Search Tools: